Syojiro Takagi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
We conducted a clinical study of MTX-HOPE (day 1, methotrexate 20 mg per os (po); day 2, hydrocortisone 100 mg intravenous (iv), vincristine 1 mg iv; day 3,4 sobuzoxane 400 mg po; etoposide 25 mg po,(More)
  • 1